A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis
published in: European Journal of Gynaecological Oncology
date of publication: 2011-01-01
main subject: phase II clinical trial, ovarian cancer, carboplatin
Cites articles
There is nothing here
Article - wd:Q84608482